Higher Incidence of SARS-CoV-2 Infection in Under 5s During Omicron

FRIDAY, April 1, 2022 (HealthDay News) -- For children aged under 5, the incidence rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was higher with the omicron variant versus the delta variant, according to a research letter published online April 1 in JAMA Pediatrics.
Lindsey Wang, from the Case Western Reserve University School of Medicine in Cleveland, and colleagues examined incidence rates of SARS-CoV-2 infection in three cohorts of children aged younger than 5 years with no prior SARS-CoV-2 infection: the omicron cohort (22,772 children), who contracted SARS-CoV-2 between Dec. 26, 2021, and Jan. 25, 2022; the delta cohort (66,692 children), who contracted SARS-CoV-2 between Sept. 1 and Nov. 15, 2021; and the delta2 cohort (10,496 children), who contracted SARS-CoV-2 between Nov. 16 and Nov. 30, 2021.
The researchers found that the monthly incidence rate of SARS-CoV-2 infections was mostly stable between September and November 2021 (1.0 to 1.5 cases per 1,000 persons/day), but increased to 2.4 to 5.6 cases per 1,000 persons/day in December 2021, coincident with omicron emergence. The monthly incidence rate of SARS-CoV-2 peaked at 8.6 and 8.2 cases per 1,000 persons/day in the first and second half of January 2022, respectively. Risks for severe clinical outcomes were significantly lower for children infected with omicron variant versus the matched delta cohort; the risks for severe clinical outcomes did not differ for the delta and delta2 cohorts.
"Study findings may inform risk-benefit considerations about in-person school attendance, mask use, and vaccination implementation for young children," the authors write.
Related Posts
Las reinfecciones con la COVID ya son comunes. ¿Los refuerzos ayudan?
LUNES, 25 de julio de 2022 (HealthDay News) -- Todo el mundo en Estados Unidos...
Lymph Node Removal During Breast Cancer Mastectomy: Is It Overdone?
THURSDAY, April 27, 2023 (HealthDay News) -- Women having a mastectomy for...
Un tratamiento hormonal en el embarazo no reduce las probabilidades de nacimiento prematuro
MIÉRCOLES, 2 de noviembre de 2022 (HealthDay News) -- Es probable que una...
Supplement Manufacturers Often Ignore FDA Warning Letters
MONDAY, Aug. 1, 2022 (HealthDay News) -- A considerable proportion of products...